A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium tuberculosis bacterium primarily affects the lungs, up to 25% of all infected people ...

Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

An early view of the immune response to bacteria in the lungs provides clues as to why some people keep TB in check, while ...

(Monday, 14 April 2025, Vienna, Austria) A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing ...

Tuberculosis often leaves survivors with lasting structural and functional lung damage despite microbiological cure. Common sequelae include airflow obstruction, restrictive defects, bronchiectasis ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

Researchers used 6MWD to assess the association between physical function and the effectiveness of ART and anti-tubercular therapy in patients with HIV/TB co-infection. In patients with TB/HIV, higher ...

Among the lung diseases, lung cancer and TB are the two most worrying conditions. Both can cause serious damage to the body. In such a situation, it is important to identify the symptoms of these ...

Nearly half of lung cancer patients die after being misdiagnosed with tuberculosis. Many clinicians, research has revealed, put patients with these symptoms; coughing, weight loss and shortness of ...